Table 1.
Proportions of respondents in (i) rounds 3–5 and (ii) round 6 who still reported one or more (or three or more) symptoms 12 weeks after initial symptom onset.
| n | n with prior symptomatic COVID-19 and 12 weeks’ observation time | % with one or more symptoms at 12 weeks | % with three or more symptoms at 12 weeks | |
|---|---|---|---|---|
| Rounds 3–5 | 508,707 | 76,155 | 37.7 [37.4–38.1] | 17.47 [17.2–17.7] |
| Round 6 | 97,727 | 13,170 | 21.6 [20.9–22.3] | 11.94 [11.4–12.5] |
| Round 6 (extended symptom list) | 22.8 [22.1–23.5] | 13.82 [13.2–14.4] |